(S (NP (PRP We)) (VP (VBP present) (NP (NP (DT the) (ADJP (NN Network) (HYPH -) (VBN based)) (JJ Biased) (NN Tree)) (NP (NP (NNS Ensembles)) (-LRB- -LRB-) (NP (NN NetBiTE)) (-RRB- -RRB-)) (NP (NP (NN method)) (PP (IN for) (NP (NP (NML (NN drug) (NN sensitivity)) (NML (NN prediction) (CC and) (NN drug)) (NN sensitivity) (NN biomarker) (NN identification)) (PP (IN in) (NP (NP (NN cancer)) (VP (VBG using) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (JJ prior) (NN knowledge)))))))))) (CC and) (NP (NML (NN gene) (NN expression)) (NNS data)))) (. .))
(S (NP (PRP$ Our) (VBN devised) (NN method)) (VP (VBZ consists) (PP (IN of) (NP (NP (DT a) (JJ biased) (NN tree) (NN ensemble)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN built) (PP (VBG according) (PP (IN to) (NP (DT a) (JJ probabilistic) (NML (NN bias) (NN weight)) (NN distribution))))))))))) (. .))
(S (NP (DT The) (NML (NN bias) (NN weight)) (NN distribution)) (VP (VBZ is) (VP (VP (VBN obtained) (PP (IN from) (NP (NP (DT the) (NN assignment)) (PP (IN of) (NP (JJ high) (NNS weights))))) (PP (IN to) (NP (DT the) (NN drug) (NNS targets)))) (CC and) (VP (VBG propagating) (NP (DT the) (VBN assigned) (NNS weights)) (PP (IN over) (NP (NP (DT a) (NML (NN protein) (HYPH -) (NN protein)) (NN interaction) (NN network)) (PP (JJ such) (IN as) (NP (NN STRING)))))))) (. .))
(S (NP (NP (DT The) (NN propagation)) (PP (IN of) (NP (NNS weights)))) (, ,) (VP (VBZ defines) (SBAR (S (NP (NP (NNS neighborhoods)) (PP (IN of) (NP (NP (NN influence)) (PP (PP (IN around) (NP (DT the) (NN drug) (NNS targets))) (CC and) (PP (IN as) (NP (JJ such))))))) (VP (VBZ simulates) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (NP (NNS perturbations)) (PP (IN within) (NP (DT the) (NN cell))))) (, ,) (PP (VBG following) (NP (NN drug) (NN administration)))))))) (. .))
(S (S (VP (VBG Using) (NP (DT a) (JJ synthetic) (NN dataset)))) (, ,) (NP (PRP we)) (VP (VBP showcase) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN application)) (PP (IN of) (NP (JJ biased) (NN tree) (NNS ensembles) (PRN (-LRB- -LRB-) (NP (NN BiTE)) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ significant) (NN accuracy) (NNS gains)) (PP (IN at) (NP (DT a) (ADJP (RB much) (JJR lower)) (JJ computational) (NML (NML (NML (NN cost)) (PP (VBN compared) (PP (IN to) (NP (DT the) (JJ unbiased) (JJ random) (NNS forests))))) (-LRB- -LRB-) (NML (NN RF)) (-RRB- -RRB-)) (NN algorithm))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB then)) (VP (VP (VBP apply) (NP (NN NetBiTE)) (PP (IN to) (NP (NP (DT the) (NNP Genomics)) (PP (IN of) (NP (NP (NNP Drug) (NNP Sensitivity)) (PP (IN in) (NP (NML (NNP Cancer) (-LRB- -LRB-) (NNP GDSC) (-RRB- -RRB-)) (NN dataset)))))))) (CC and) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNP NetBiTE)) (VP (VBZ outperforms) (NP (NN RF)) (PP (PP (IN in) (S (VP (VBG predicting) (NP (NML (NN IC50) (NN drug)) (NN sensitivity))))) (, ,) (RB only) (PP (IN for) (NP (NP (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP target) (NP (NML (NN membrane) (NN receptor)) (NNS pathways)))))) (-LRB- -LRB-) (NP (NNS MRPs)) (-RRB- -RRB-)) (: :) (NP (NP (NNP RTK) (, ,) (NNP EGFR) (CC and) (NNP IGFR)) (NP (NN signaling) (NNS pathways))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (SBAR (S (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NNP NetBiTE) (NNS results)) (, ,) (NP (NP (DT that)) (PP (IN for) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NNS MRPs))))))))))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN target) (NNS genes)) (PP (JJ prior) (IN to) (NP (NN drug) (NN administration)))))) (VP (VBZ is) (NP (NP (DT a) (NN biomarker)) (PP (IN for) (NP (NP (NN IC50) (NN drug) (NN sensitivity)) (PP (VBG following) (NP (NN drug) (NN administration)))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB further)) (VP (VBP verify) (CC and) (VBP reinforce) (NP (NP (DT this) (NN proposition)) (PP (PP (IN through) (NP (NP (NN control) (NNS studies)) (PP (IN on) (, ,) (NP (NP (NML (NN PI3K) (HYPH /) (NN MTOR)) (NN signaling) (NN pathway) (NNS inhibitors)) (, ,) (NP (NP (DT a) (NN drug) (NN category)) (SBAR (WHNP (WDT that)) (S (VP (VBZ does) (RB not) (NP (NN target) (NNS MRPs)))))))))) (, ,) (CC and) (PP (IN through) (NP (NP (NN assignment)) (PP (IN of) (NP (NP (JJ dummy) (NNS targets)) (PP (IN to) (NP (NNP MRP))))))))) (S (VP (VP (VBG inhibiting) (NP (NNS drugs))) (CC and) (VP (VBG investigating) (NP (NP (DT the) (NN variation)) (PP (IN in) (NP (NNP NetBiTE) (NN accuracy)))))))) (. .))
